UK Dna Diagnostics Market Size & Outlook, 2024-2030
UK dna diagnostics market, 2018-2030 (US$M)
UK dna diagnostics market highlights
- The UK dna diagnostics market generated a revenue of USD 254.7 million in 2023 and is expected to reach USD 344.2 million by 2030.
- The UK market is expected to grow at a CAGR of 4.4% from 2024 to 2030.
- In terms of segment, pcr-based diagnostics was the largest revenue generating technology in 2023.
- NGS DNA Diagnosis is the most lucrative technology segment registering the fastest growth during the forecast period.
Dna diagnostics market data book summary
| Market revenue in 2023 | USD 254.7 million |
| Market revenue in 2030 | USD 344.2 million |
| Growth rate | 4.4% (CAGR from 2023 to 2030) |
| Largest segment | Pcr-based diagnostics |
| Fastest growing segment | NGS DNA Diagnosis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | PCR-based Diagnostics, NGS DNA Diagnosis, In-Situ Hybridization Diagnostics, Microarrays-based Diagnostics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corp, Hologic Inc, Siemens Healthineers AG ADR, Roche, Qiagen NV, Agilent Technologies Inc |
Other key industry trends
- In terms of revenue, UK accounted for 2.4% of the global dna diagnostics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany dna diagnostics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 344.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNA Diagnostics Market Scope
DNA Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK dna diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna diagnostics market will help companies and investors design strategic landscapes.
Pcr-based diagnostics was the largest segment with a revenue share of 49.78% in 2024. Horizon Databook has segmented the UK dna diagnostics market based on pcr-based diagnostics, ngs dna diagnosis, in-situ hybridization diagnostics, microarrays-based diagnostics covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of sophisticated healthcare infrastructure, collaborations between key players, and an increasing number of novel product launches are anticipated to contribute to market growth in the UK. Moreover, government support & initiatives are expected to propel the DNA diagnostics market in the coming decade.
According to an article published by HEE Genomics Education Programme in March 2023, the UK National Screening Committee (UK NSC) recently suggested that all newborn blood spot testing programs in England, Scotland, Wales, and Northern Ireland include a genetic disorder known as tyrosinaemia type 1. Moreover, across the nation, newborn blood spot screening may soon include the rare illness tyrosinaemia type 1. Such programs are anticipated to contribute to future market growth.
Reasons to subscribe to UK dna diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK dna diagnostics market databook
-
Our clientele includes a mix of dna diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK dna diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UK dna diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK dna diagnostics market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
